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ABSTRACT  
The bloodstream form of the human 
pathogen Trypanosoma brucei expresses 
oligomannose, paucimannose and complex N-
linked glycans, including some exceptionally large 
poly-N-acetyllactosamine-containing structures. 
Despite the presence of complex N-glycans in this 
organism, no homologues of the canonical N-
acetylglucosaminyltransferase I or II genes can be 
found in the T. brucei genome. These genes 
encode the activities that initiate the elaboration of 
the Manα1-3 and Manα1-6 arms, respectively, of 
the conserved trimannosyl-N-acetylchitobiosyl 
core of N-linked glycans.  
Previously, we identified a highly divergent 
T. brucei N-acetylglucosaminyltransferase I 
(TbGnTI) among a set of putative T. brucei 
glycosyltransferase genes belonging to the β3-
glycosyltransferase superfamily (1). Here, we 
demonstrate that TbGT15, another member of the 
same β3-glycosyltransferase family, encodes an 
equally divergent N-acetylglucosaminyltransferase 
II (TbGnTII) activity. In contrast to multicellular 
organisms, where GnTII activity is essential, 
TbGnTII null mutants of T. brucei grow in culture 
and are still infectious to animals. 
 Characterization of the large poly-N-
acetyllactosamine containing N-glycans of the 
TbGnTII null mutants by methylation linkage 
analysis suggests that, in wild-type parasites, the 
Manα1-6 arm of the conserved trimannosyl core 
may carry predominantly linear poly-N-
acetyllactosamine chains whereas the Manα1-3 
arm may carry predominantly branched poly-N-
acetyllactosamine chains. These results provide 
further detail on the structure and biosynthesis of 
complex N-glycans in an important human 
pathogen and provide a second example of the 
adaptation by trypanosomes of β3-
glycosyltransferase family members to catalyze 
β1-2 glycosidic linkages.  
The African trypanosomes are protozoan 
parasites that cause human African sleeping 
sickness and Nagana in cattle. The parasite 
undergoes a complex life cycle between the 
mammalian host and the blood-feeding tsetse fly 
vector (Glossina sp.). Throughout this life cycle, 
T. brucei is coated by glycosylphosphatidylinositol 
(GPI)6 anchored proteins. The bloodstream form 
of the parasite in the mammalian host is covered 
by a coat of 5 x 106 variant surface glycoprotein 
(VSGs) homodimers and evades the immune 
system by replacing one VSG coat by another, in a 
process known as antigenic variation (2-4). The 
VSG GPI anchors contain sidechains of 0-6 Gal 
residues, depending on the VSG variant (5-7) and 
between 1 and 3 N-linked glycans. The latter can 
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be of oligomannose, paucimannose or complex 
types (6,8,9). T. brucei expresses numerous other 
GPI-anchored and transmembrane glycoproteins at 
the cell surface, in the flagellar pocket and in the 
intracellular endosomal/lysosomal system, some 
of which are lifecycle stage-specific or display 
lifecycle stage-specific glycosylation differences. 
For example, the transmembrane invariant surface 
glycoproteins ISG65 and ISG75 (10) and the GPI-
anchored flagellar pocket ESAG6/ESAG7 
heterodimeric transferrin receptors (11-13) are 
specific to the bloodstream lifecycle stage while 
the major lysosomal glycoprotein p67 is common 
to bloodstream and procyclic stages but contains 
complex N-glycans only in the bloodstream stage 
(14). This control of stage-specific glycosylation 
resides primarily at the level of 
oligosaccharyltransferase (OST) expression (15). 
Thus, in bloodstream form T. brucei both the 
TbSTT3A and TbSTT3B genes are expressed and it 
appears that TbSTT3A co-translationally scans for 
glycosylation sequons in relatively acidic local 
environments, transferring exclusively 
Man5GlcNAc2 that is destined to be processed to 
paucimannose or complex N-glycans, while 
TbSTT3B post-translationally modifies any 
remaining sequons with Man9GlcNAc2 that is 
destined to be processed no further than 
Man5GlcNAc2 in the conventional oligomannose 
series. Conversion from the oligomannose series 
to the complex series by the conventional 
mammalian-type route cannot occur because the 
parasite lacks a Golgi α-mannosidase II gene (16). 
In procyclic form T. brucei, the expression of 
TbSTT3A is repressed at both the mRNA level (15) 
and protein level (17), favouring the transfer of 
Man9GlcNAc2 and the predominant expression of 
the conventional Man5GlcNAc2 - Man9GlcNAc2 
oligomannose series (18).  
The survival strategies of protozoan 
parasites frequently involve the participation of 
glycoconjugates. T. brucei expresses many 
glycoproteins containing Gal and GlcNAc, 
including glycoproteins with novel bloodstream 
form-specific giant poly-N-acetyllactosamine 
(poly-LacNAc) containing N-linked glycans (19). 
The creation of UDP-glucose 4'-epimerase 
(TbGalE) conditional null mutants showed that 
this gene, and hence UDP-Gal, is essential for the 
survival of the parasite in both the bloodstream 
and procyclic form lifestages (20-22). Similarly, 
the creation of a UDP-GlcNAc pyrophosphorylase 
(TbUAP) and glucosamine 6-phosphate N-
acetyltransferase (TbGNA) conditional null 
mutants has shown that UDP-GlcNAc is essential 
for bloodstream form T. brucei (23,24). From 
these experiments, it is possible to conclude that 
one or more of the UDP-Gal- and UDP-GlcNAc-
dependent glycosylation pathways are essential to 
the parasite. This has provided the impetus to 
identify and characterize the UDP-Gal and UDP-
GlcNAc-dependent glycosyltransferase (GT) 
genes in the parasite. We previously reported a 
family of 21 genes with predicted amino acid 
sequences consistent with being UDP-sugar-
dependent GTs. All 21 putative T. brucei GT 
amino acid sequences are similar to those of the 
mammalian β3GT family (25). The mammalian 
β3GT family includes Gal, Glc, GlcA, GlcNAc 
and GalNAc β-3 transferases and its members 
contain N-terminal transmembrane domains 
followed by three conserved motifs of: 
(I/L)RXXWG, (F/Y)(V/L/M)XXXDXD and 
(E/D)D(A/V)(Y/F)XGX(C/S). The comparable 
motifs in the T. brucei genes are slightly different: 
WG, Y(I,V,F)XKXDDD and 
ED(A/V/I/L/M)(M/L)X(G/A) but, nevertheless, 
identify the parasite genes as belonging to the 
β3GT superfamily (26). One of these genes 
(TbGT8) encodes a β1-3 GlcNAc transferase and 
another (TbGT3) a β1-3 Gal transferase that 
modify the complex GPI anchor sidechains of the 
procyclins (the major surface glycoproteins of the 
procyclic lifecycle stage) (26-28). However, we 
recently reported that another gene (TbGT11) 
encodes a β1-2 GlcNAc transferase that performs 
a similar role to members of the N-
acetylglucosaminyltransferase I family, in that it 
transfers GlcNAc in β1-2 linkage to the 3-arm of 
Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc 
(1).  
Here, we report that another T. brucei 
β3GT superfamily gene member (TbGT15) 
encodes another β1-2 GlcNAc transferase, already 
localized to the Golgi apparatus (29,30), that 
performs a similar role to members of the N-
acetylglucosaminyl transferase II family, in that it 
transfers GlcNAc in β1-2 linkage to the 6-arm of 
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Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-
4GlcNAc, emphasizing the highly divergent nature 
of the trypanosome genes involved in structurally-
conserved aspects of complex N-glycan 
biosynthesis.   
  
EXPERIMENTAL PROCEDURES 
Cultivation of Trypanosomes—
Trypanosoma brucei brucei strain 427 
bloodstream form parasites, expressing VSG 
variant 221 and transformed to stably express T7 
polymerase and the tetracycline repressor protein 
under G418 antibiotic selection (31), were used in 
this study. This genetic background will be 
referred to from hereon as wild-type (WT). Cells 
were cultivated in HMI-9 medium containing 2.5 
μg/ml G418 at 37 °C in a 5% CO2 incubator as 
described in (31).  
DNA & RNA Isolation and Manipulation—
Plasmid DNA was purified from Escherichia coli 
(α-select chemically competent cells, Bioline, 
London, UK) using Qiagen Miniprep or Maxiprep 
kits, as appropriate. Gel extraction and reaction 
cleanup was performed using Qiaquick kits 
(Qiagen). Custom oligonucleotides were obtained 
from Eurofins MWG Operon or the Dundee 
University oligonucleotide facility. T. brucei 
genomic DNA was isolated from ∼2×108 
bloodstream form cells using DNAzol (Helena 
Biosciences, UK) using standard methods. T. 
brucei mRNA was extracted from 1×107 cells 
using RNeasy RNA extraction kit (Qiagen).  
Generation of gene replacement 
constructs—The 517-bp 5’ and 454-bp 3’ UTR 
sequences next to the Tb427.7.300 ORF were 
PCR-amplified from genomic DNA using Pfu 
DNA polymerase with primers 5’-
cgttGTCGACagtatccgcaaaatgcgact-3’ and 5’-
gtttaaacttacggaccgtcaagctttatttttctttccctacgcac-3’, 
5’- 
gacggtccgtaagtttaaacggatccaaagcggaataaaaataaatc-
3’ and 5’-
ataagtaaGCGGCCGCagatgtcgcgcaagaaaaac-3’ as 
forward and reverse primers, respectively. The two 
PCR products were used together in a further PCR 
reaction to yield a product containing the 5′-UTR 
linked to the 3′-UTR by a short HindIII 
(underlined), PmeI (italics), and BamHI 
(underlined) cloning site and NotI and SalI 
restriction sites at each end (capital letters). The 
product was cloned between the NotI and SalI sites 
of the pGEM-5Zf(+) vector (Promega).  
The hygromycin phosphotransferase (HYG) 
and puromycin acetyltransferase (PAC) drug-
resistance genes were then introduced into the 
targeting vector via the HindIII and BamHI 
cloning sites. For re-expression of Tb427.7.300 
the ORF was PCR-amplified from genomic DNA 
with the primer pair 5’-
agaaagcttatggtgtggagtgggcataaa-3’ and 5’- 
ttcagatcttcatgtgcacgaggcgtgcca-3’ and cloned into 
pLEW100-Phleo (31).  
For overexpression of full-length TbGT15 
with a C-terminal 3x HA epitope tag, a plasmid 
was generated based on the trypanosome 
expression vector pLEW82 (31). TbGT15 ORF 
was amplified from T. brucei genomic DNA and 
the primers 5’-
gactaagcttatggtgtggagtgggcataaatac-3’ and 5’-
gact ttaattaatgcgtaatcagggacgtcataaggatatgcgtaatc
agggacgtcataaggatacgctcccgcTGTGCACGAGGC
GTGCCATC-3’ containing a HindIII and PacI 
restriction site (underlined), respectively. The 
sequence encoding for two HA tags (italics) 
followed by a sequence encoding an Ala-Gly-Ala 
linker was attached as a 5’overhang of the reverse 
primer. The PCR product was subcloned into 
pLEW82-GPIdeAc-HA (32) via HindIII and PacI 
restriction sites under replacement of the GPIdeAc 
insert, but retention of the sequence encoding for 
one HA tag, resulting in the plasmid pLEW82-
TbGT15-HA3. The identity of all constructs was 
confirmed by sequencing. 
Transformation of bloodstream form 
T. brucei—Constructs for gene replacement and 
ectopic expression were purified, digested with 
NotI to linearize, precipitated, washed with 70% 
ethanol, and re-dissolved in sterile water. The 
linearized DNA was electroporated into T. brucei 
bloodstream form cells (strain 427, variant 221) 
that were stably transformed to express T7 RNA 
polymerase and the tetracycline repressor protein 
under G418 selection. Cell culture and 
transformation was carried out as described 
previously (31-33). 
Southern blotting—Aliquots of genomic 
DNA isolated from 100 ml of bloodstream form T. 
brucei cultures (∼2×108 cells) were digested with 
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EcoRI, resolved on a 0.8% agarose gel and 
transferred onto a Hybond-N positively charged 
membrane (GE Healthcare, Amersham, UK). 
Highly-sensitive DNA probes labelled with DIG-
dUTP were generated using the PCR DIG Probe 
Synthesis Kit (Roche) according to the 
manufacturer’s recommendations and hybridized 
overnight at 42°C. Detection was performed using 
alkaline phosphatase conjugated anti-digoxigenin 
Fab fragments and the chemiluminescent substrate 
CSPD (Roche). 
Mouse infectivity studies—Wild-type and 
TbGT15 null mutant bloodstream form 
trypanosomes were grown in HMI-9T media, 
washed in media without antibiotics and 
resuspended at 5x106 cells/ml. Groups of 5 female 
Balb/c mice were used for each cell line and 
0.1 ml of the suspension above was injected 
intraperitoneally per animal. Infections were 
assessed three days post-infection by tail bleeding 
and cell counting using a Neubauer chamber in a 
phase contrast microscope. 
Semi-quantitative RT-PCR—In order to 
assess the amount of Tb427.7.300 mRNA in the 
TbGT15 conditional null mutant cells grown under 
permissive and non-permissive conditions, RT-
PCR reactions were performed using AccessQuick 
RT-PCR System (Promega) according to the 
manufacturer’s recommendations. A TbGT15 
350 bp fragment was amplified with the primer 
pair 5’-cacattgtcgcgggatgtgagtgag-3’ and 5’-
ccatcccaagtacccgcggtaaaatggg-3’. As a control to 
ensure similar RNA levels in both samples, 
primers 5’-aatggatgcggaccttcagcacccac-3’ and 5’-
tagaaccgtgagcgcggtgccatac-3’ amplifying a 448 bp 
product of dolichol phosphate mannose synthase 
(Tb10.70.2610) were used. 
Small scale sVSG isolation—Soluble-form 
VSG (sVSG) was isolated from 100 ml of cultures 
containing ∼2×108 bloodstream form T. brucei by 
a modification of the method of Cross (34,35) as 
described in (36). Briefly, cells were chilled on 
ice, centrifuged at 2500×g for 10 min and washed 
in an isotonic buffer. The pellet was resuspended 
in 300 μl of lysis buffer (10 mM NaH2PO4 buffer, 
pH 8.0, containing 0.1 mM tosyllysine 
chloromethyl ketone hydrochloride (TLCK), 
1 μg/ml leupeptin, and 1 μg/ml aprotinin) and 
incubated for 5 min at 37 °C. The sample was 
centrifuged at 14,000×g for 5 min, and the 
supernatant was applied to a 200-μl DE52 anion 
exchange column pre-equilibrated in 10 mM 
sodium phosphate buffer, pH 8.0. Elution was 
performed with 0.8 ml of 10 mM sodium 
phosphate buffer, pH 8.0, the eluate was 
concentrated and diafiltered with water on a YM-
10 spin concentrator (Microcon). The final sample 
of 50–100 μg sVSG221 was recovered in a 
volume of 100 μl of water. 
ES-MS analysis of intact sVSG—50 μg 
aliquots of sVSG preparations were diluted to 
∼0.05 μg/μl in 50% methanol, 1% formic acid and 
analyzed by positive ion ES-MS on a Q-Tof 6520 
instrument (Agilent). Data were collected, 
averaged, and processed using the maximum 
entropy algorithm of the MassHunter software 
(Agilent). 
Lectin blotting of cell extracts—To analyze 
N-glycosylation of T. brucei bloodstream form 
cells, ∼2×108 cells were first depleted of VSG by 
hypotonic lysis (34,35). For Western blot analysis, 
residual cell ghosts were solubilized in SDS 
sample buffer containing 8 M urea, boiled with 
DTT, separated by SDS–PAGE (approx. 
1×107 cell equivalents/lane) on NuPAGE bis-Tris 
4–12% gradient acrylamide gels (Invitrogen) and 
transferred to nitrocellulose membrane 
(Invitrogen). Ponceau S staining confirmed equal 
loading and transfer. Glycoproteins were probed 
with 1.7 μg/ml biotin-conjugated ricin (RCA-120, 
Vector Laboratories, UK) in PBS before or after 
pre-incubation with 10 mg/ml D-galactose and 
10 mg/ml α-lactose to confirm specific ricin 
binding. Detection was performed using IRDye 
680LT-conjugated Streptavidin and the LI-COR 
Odyssey Infrared Imaging System (LICOR 
Biosciences, Lincoln, US). 
Structural analysis of the large N-glycan 
fraction—Bloodstream form cells of wild-type and 
TbGT15 null mutant cells were isolated from 
infected rats and processed as described (19). 
Briefly, VSG-depleted cell ghosts of 1×1011 cell 
equivalents were solubilized with SDS/urea buffer 
followed by lectin affinity chromatography using 
ricin-agarose (RCA-120, Vector Laboratories). N-
glycans from the ricin-binding glycoproteins were 
released with PNGase-F (Flavobacterium 
meningosepticum, Roche) and applied to a Bio-
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Gel P-4 gel filtration column. Aliquots of eluted 
fractions were subjected to methanolysis, 
trimethylsilylation and GC-MS monosaccharide 
composition analysis (37). Fractions that eluted in 
the void volume of the column (the total poly-
LacNAc fraction, rich in Gal and GlcNAc) were 
pooled and used for methylation linkage analysis. 
After permethylation, acid hydrolysis, NaBD4 
reduction and acetylation, the resulting partially 
methylated alditol acetates (PMAAs) were 
analyzed by GC-MS (Agilent) as described 
previously (38). Authentic glycans of Galβ1-
4GlcNAcβ1-2Manα1-6(Galβ1-4GlcNAcβ1-
2Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc, lacto-
N-neohexaose Galβ1-4GlcNAcβ1-6(Galβ1-
4GlcNAcβ1-3)Galβ1-4Glc, lacto-neotetraose 
Galα1-4Glclβ1-3Galβ1-4GlcNAc and Galβ1-6Gal 
(Dextra Laboratories, UK) were subjected to 
methylation linkage analysis alongside the 
experimental samples. Using the PMAA derivative 
derived from non-reducing terminal galactose 
residues, common to all of these structures (i.e., 
1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl-
1[2H]galactitol), we were able to inter-relate these 
data and determine the total ion current molar 
relative response factors (MRRFs) for the PMAAs 
derived from terminal-Gal, 3-O-substituted Gal, 6-
O-substituted Gal 3,6-di-O-sustituted Gal, 2-O-
substitued Man, 3,6-di-O-substituted Man and 4-
O-substituted GlcNAc (1.59, 0.99, 0.27, 0.90, 
1.20, 1.00 and 0.23, respectively). These MRRF 
values were used to correct the peak integrations 
of sample PMAA total ion current chromatograms 
and thus provide molar ratios of the PMAAs in the 
methylation linkage analyses of the wild-type and 
TbGT15 null glycan samples.  
 GnTII in vitro activity assay—TbGT15 
fused to a C-terminal triple HA-tag was 
overexpressed in T. brucei bloodstream form cells. 
1×109 cells were lysed on ice in 25 mM Tris 
pH 7.5; 100 mM NaCl; 1% TritonX-100 
containing a cocktail of protease inhibitors 
(CompleteMini, Roche) and 0.1 mM TLCK. 
Expression was confirmed by SDS-PAGE and 
Western blotting. Briefly, 5×106 cell 
equivalents/lane were separated on NuPAGE bis-
Tris 4–12% gradient acrylamide gels (Invitrogen) 
and transferred to nitrocellulose membrane 
(Invitrogen). Ponceau S staining confirmed equal 
loading and transfer. Detection was performed 
using 0.5 μg/ml rabbit-anti-HA antibody (QED 
Bioscience Inc., San Diego, US) and IRDye 
680LT conjugated donkey-anti-rabbit IgG and the 
LI-COR Odyssey Infrared Imaging System 
(LICOR Biosciences, Lincoln, US). For the in 
vitro activity assay, TbGT15-HA3 was 
immunoprecipitated using anti-HA bead magnetic 
beads (Pierce) and incubated with 1 μCi UDP-
[3H]-GlcNAc (specific activity of 20-40 Ci/mmol, 
Perkin Elmer, Waltham, US), 1 mM cold UDP-
GlcNAc (Sigma) and 5 μg of oligomannose-3 (a) 
or 25 μg α1-3,α1-6 mannotriose (both Dextra 
Laboratories, Reading, UK) in 50 mM Tris pH 
7.5; 10 mM MgCl2; 10 mM MnCl2 in a total 
volume of 50 μl. After overnight incubation under 
vigorous shaking at room temperature, samples 
were desalted via a mixed-bed ion exchange 
column of 100 µl Chelex-100 (Na+) over 100 µl 
AG50X12 (H+) over 200 µl AG3X4 (OH-) over 
100 µl QAE- Sephadex25 (OH-), all from Bio-Rad 
Laboratories, UK except QAE-Sephadex (Sigma). 
Finally, glycans were freeze-dried, re-dissolved in 
20% 1-propanol and aliquots were spotted onto 
silica HPTLC plates (SI-60 HPTLC, Millipore) 
which were run twice in 1-propanol:acetone:H2O 
(9:6:4). For product analysis, samples were treated 
with 128 units α1-2,3 mannosidase from 
Xanthomonas manihotis (NEB) or 0.2 units β-N-
acetylglucosaminidase from Canavalia ensiformis 
(Sigma-Aldrich) before TLC analysis. Plates were 
then dried, sprayed with EN3HANCE 
autofluorography enhancer (EN3HANCE, Perkin 
Elmer, Waltham, US), and exposed on X-ray film 
at −80°C for 1-2 days.  
For mass spectrometric analysis of the 
reaction product, the assay was performed using 5 
mM non-radioactive UDP-GlcNAc. Samples were 
analyzed by LC-MS using a HILIC column 
(Tosoh TSKgel Amide column, 1 mm x 10 cm) 
and a gradient of 80-5% acetonitrile in 0.1% 
formic acid at a flow rate of 50 μl/min using a 
TSQ Quantiva triple-quadrupole mass 
spectrometer (Thermo Fisher Scientific). For 
methylation linkage analysis of the product, 
glycans were converted to constituent 
monosaccharides in the form of partially 
methylated alditol acetates and analyzed by GC-
MS as described above.  
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Scanning electron microscopy—To analyze 
bloodstream form cells by scanning electron 
microscopy (SEM), cells were fixed in HMI-9 
medium with 2.5% glutaraldehyde. They were 
further processed and examined in a Philips XL30 
ESEM operating at an accelerating voltage of 
15kV by the Centre for High Resolution Imaging 
and Processing (CHIPS) at the University of 
Dundee. 
 
RESULTS 
Analysis of the TbGT15 gene product—We 
previously characterized the biological function of 
three members of a family of putative UDP-sugar 
dependent GTs (1,26,39). In the present study, 
Tb927.7.300 was selected for functional analysis. 
The gene encodes for a 367-amino acid protein 
with a theoretical molecular mass of 43.1 kDa. 
SILAC-based quantitative proteomic data 
demonstrated that the protein expression level is 
15 times higher in bloodstream form parasites 
compared to procyclic form parasites (40). 
The T. brucei strain that was used in this 
study (Lister strain 427) differs from the one that 
was used for the reference genome sequencing 
project (TREU927). However, an alignment of 
Tb927.7.300 and its homologue Tb427.7.300 
revealed a very high similarity with only 3 single 
nucleotide polymorphisms, none of them resulting 
in amino acid changes. The strain 427 gene and 
protein product will be referred to here as TbGT15 
and TbGT15, respectively.  
The protein sequence contains several 
hallmarks of Golgi apparatus glycosyltransferases. 
First, a membrane protein topology prediction 
program based on a hidden Markov model (41) 
designates TbGT15 as a type II transmembrane 
protein. In addition, the sequence contains a DXD 
motif, which is generally involved in catalytic 
activity of known GTs (42) as well as a dibasic 
motif, which functions as an ER exit signal (43). 
Indeed, a subcellular Golgi localization of 
TbGT15 was confirmed previously (29,30). 
Creation of bloodstream form TbGT15 null 
and conditional null mutants – As TbGT15 is 
predominantly expressed in bloodstream form 
parasites (40), we decided to investigate the 
protein function by creating null and conditional 
null mutants in this life cycle stage. BLAST search 
of the T. brucei genome suggested that TbGT15 is 
present as a single copy per haploid genome. Both 
alleles were sequentially replaced by homologous 
recombination using PAC and HYG drug 
resistance cassettes as summarized in Fig. 1 A. 
After selection on the respective antibiotics, the 
generation of a TbGT15 null mutant 
(ΔTbGT15::PAC/ΔTbGT15::HYG) was confirmed 
by Southern blot using probes for the TbGT15 
ORF and 3’ UTR (Fig. 1B). To allow for a 
tetracycline inducible re-expression of the gene, an 
ectopic copy of TbGT15 was introduced into the 
rRNA locus of the null mutant background using 
the pLEW100 vector (31). Clones were selected 
on phleomycin and the creation of this conditional 
null mutant 
(ΔTbGT15Ti/ΔTbGT15::PAC/ΔTbGT15::HYG) 
was confirmed by RT-PCR (Fig. 1 C). 
No morphological differences between the 
WT and TbGT15 null mutant parasites could be 
ascertained by light microscopy or by scanning 
electron microscopy (Fig. 2 A). Compared to WT 
cells, the TbGT15 null mutant parasites exhibited 
slightly slower growth kinetics in vitro and this 
mild growth phenotype was partially reversed in 
TbGT15 conditional null cells grown under 
permissive conditions (Fig. 2B). In addition, no 
difference in its ability to infect mice could be 
detected for the TbGT15 null mutant (Fig. 2 C). 
From this we can conclude that TbGT15 is a non-
essential gene in T. brucei bloodstream form cells. 
Characterization of VSG from WT and 
TbGT15 Null Mutant Parasites – VSG221 from 
WT cells is heterogeneously glycosylated, 
containing a highly galactosylated GPI anchor (5), 
one oligomannose N-glycan at Asn-428 (Man5-
9GlcNAc2) as well as small biantennary structures 
ranging from Man3GlcNAc2 to 
Gal2GlcNAc2Man3GlcNAc2 at Asn-296 (8,16). 
VSG can be isolated in its soluble form (sVSG) by 
hypotonic lysis, which results in its release by of 
endogenous GPI-specific phospholipase C (44).  
To assess differences in the glycosylation 
phenotype, intact sVSGs from WT and TbGT15 
null mutant parasites were analyzed by ES-MS in 
positive-ion mode (Fig. 3). VSG molecules 
containing a total of four or five GlcNAc residues 
were present at similar levels in both genotypes 
but glycoforms with six GlcNAc residues were 
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completely absent in the TbGT15 null mutant (see 
arrows in Fig. 3B and Table 1). Bearing in mind 
that four GlcNAc residues are necessary for the 
composition of the two N-glycan N-
acetylchitobiose core structures, the lack of VSG 
glycoforms containing six GlcNAc residues 
strongly indicates a deficiency in biantennary 
complex N-glycans at Asn-296. From this we can 
conclude that the mutant cells are unable to 
express complex N-glycans and that TbGT15 is 
involved in their biosynthesis.  
In vitro functional activity assay – In order 
to verify that TbGT15 encodes a 
glycosyltransferase that is directly involved in the 
biosynthesis of hybrid or complex N-glycans, we 
performed an in vitro assay for enzymatic activity 
as described in (1). Briefly, full length TbGT15 
fused to a C-terminal 3x HA epitope tag was 
expressed in T. brucei bloodstream form cells and 
immunoprecipitated using anti-HA magnetic 
beads. The protein was incubated with Manα1-
6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc as 
acceptor substrate and tritium-labelled UDP-
[3H]GlcNAc as donor substrate. Following 
desalting and removal of excess UDP-[3H]GlcNAc 
donor by mixed-bed ion exchange, aliquots were 
separated by thin-layer chromatography (TLC) 
and analyzed by fluorography. While a control 
immunoprecipitation with lysate from WT cells 
did not result in any [3H]GlcNAc incorporation 
(Fig. 4 A, lane 2), the sample containing TbGT15-
HA3 showed a strong signal of tritium-labelled 
reaction product (Fig. 4 A, lane 1). This 
demonstrates that TbGT15 is able to transfer 
GlcNAc to biantennary Manα1-6(Manα1-
3)Manβ1-4GlcNAcβ1-4GlcNAc core structures. It 
is noteworthy that the shortened substrate Manα1-
6(Manα1-3)Man lacking the chitobiose core was 
not used as an UDP-GlcNAc acceptor by TbG15 
(Fig. 4, lane 3). 
To reveal whether GlcNAc is transferred to 
the Manα1-3 or Manα1-6 arm of Manα1-
6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc, the 
reaction product was treated with α1-2,3 
mannosidase. As seen in the subsequent TLC/ 
autofluorography analysis, mannosidase treatment 
caused an increased mobility of the reaction 
product (compare Rf values in Fig. 4 B). This 
suggests that the 3-Man arm was not modified by 
TbGT15, leaving it susceptible to exoglycosidase 
cleavage, and allows us to conclude that the 
transferred GlcNAc residue is attached to the 6-
Man arm of the Manα1-6(Manα1-3)Manβ1-
4GlcNAcβ1-4GlcNAc core structure. The 
anomeric configuration of the newly formed 
linkage was determined by β-N-
acetylglucosaminidase digestion of the reaction 
product. In the following TLC/ autofluorography 
analysis the band of tritium-labelled 
GlcNAcMan3GlcNAc2 disappeared while the 
amount of free [3H]GlcNAc increased, 
demonstrating a β-configuration (Fig. 4 C).  
For further characterisation of the reaction 
product, the assay was performed using non-
radioactive UDP-GlcNAc. First, HILIC-MS was 
performed to identify the HexNAc3Hex3 reaction 
product (Fig. 5 A, B). A subsequent methylation 
linkage analysis on the reaction sample by GC-MS 
demonstrated the presence of 1,2,5-tri-O-acetyl-(1-
deutero)-3,4,6-tri-O-methyl-mannitol, originating 
from 2-O-substitued mannose, which reveals that 
TbGT15 transfers GlcNAc in a 1-2 linkage to one 
of the non-reducing terminal mannose residues of 
the trimannosyl core (Fig. 5 C, D).  
Taken together, these data show that 
TbGT15 is the glycosyltransferases responsible for 
the transfer of β1-2-linked GlcNAc to the α1-6-
linked α-D-mannopyranosyl residue of Manα1-
6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc and 
can, therefore, be termed an N-
acetylglucosaminyltransferase type II or TbGnTII. 
N-glycosylation phenotype of bloodstream 
form TbGT15 mutant parasites – To investigate 
the effect of TbGT15 on the glycosylation of other 
proteins than VSG, total glycoproteins were 
extracted with SDS/urea from VSG-depleted 
trypanosome ghosts and analyzed by lectin 
blotting. As previously reported for WT T. brucei, 
ricin (RCA-120), a lectin that predominantly binds 
to non-reducing terminal β-galactose residues, 
showed strong binding to a series of glycoproteins 
running between 60 kDa and 150 kDa (Fig. 6, lane 
1). Ricin binding to glycoproteins extracted from 
the TbGT15 null mutants was slightly reduced and 
the apparent molecular mass of all signals was 
marginally smaller compared to WT signals (Fig. 
6, lane 2). Albeit subtle, these changes in blotting 
pattern suggest an alteration in the synthesis of the 
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large poly-LacNAc-containing glycans of the 
high-molecular-weight invariant glycoproteins 
(19).  
In order to draw structural conclusions, we 
decided to analyze the ricin-binding glycoprotein 
fraction by methylation linkage as described in 
(19). Briefly, WT and TbGT15 null mutant cells 
were isolated, depleted of VSGs, solubilized in 
SDS/urea and glycoproteins were purified by ricin 
affinity chromatography. N-linked glycans were 
released by PNGaseF and further fractionated by 
Bio-Gel P-4 gel filtration, resulting in two main 
factions: one containing the relatively small 
mannose-rich N-glycans, and a Gal/GlcNAc-rich 
high molecular mass fraction eluting at the void 
volume of the Bio-Gel P-4 column (the total poly-
LacNAc fraction). Aliquots of these fractions were 
subjected to neutral monosaccharide composition 
analysis by GC-MS. The molar ratios of Gal : Man 
in the total poly-LacNAc fraction for WT (19) and 
TbGT15 null mutant parasites were found to be 
similar; 14.5 : 1 and 12.4 : 1, respectively. 
Subsequent GC-MS methylation linkage 
analysis of the total poly-LacNAc fraction 
revealed structural similarities, but also some 
quantitative differences (Table 2). Thus, both WT 
and TbGT15 null total poly-LacNAc glycans 
contain 2-O-substituted Man and 3,6-di-O-
substituted Man, consistent with a conventional 
core structure of R-2Manα1-6(R’-2Manα1-
3)Manβ1-4GlcNAcβ1-4GlcNAc in all structures. 
Further, both samples contained significant 
amounts of 4-O-substituted GlcNAc, indicating 
the presence of multiple LacNAc repeats. 
However, whereas the numbers of terminal Gal 
residues were similar, there was a significant 
decrease in 6-O-substituted Gal and 3-O-
substituted Gal residues and a concomitant 
increase in 3,6-di-O-substituted-Gal residues in the 
TbGT15 null mutant glycans. Since TbGT15 has a 
GnTII-type activity that initiates elaboration of the 
Manα1-6 arm of Manα1-6(Manα1-3)Manβ1-
4GlcNAcβ1-4GlcNAc core, these data are 
consistent with a model where linear poly-LacNAc 
chains predominate on the Manα1-6 arm, whereas 
the Manα1-3 arm is occupied by both linear and 
branched poly-LacNAc units (Fig. 7). The increase 
in the number of 3,6-di-O-substituted Gal residues 
in the TbGT15 mutant glycans further suggests 
that deletion of the entire (predominantly linear) 
poly-LacNAc chain attached to the Manα1-6 arm 
is, to some extent, compensated by further 
elaboration of the (linear and branched) poly-
LacNAc chain attached to the Manα1-6 arm. 
 
DISCUSSION 
We have cloned the gene which encodes 
UDP-GlcNAc:α1-6-D-mannoside-β1-2-N-
acetylglucosaminyltransferase II in T. brucei, an 
enzyme that catalyzes an essential step on the 
route to complex N-glycans. In human patients 
with carbohydrate-deficient glycoprotein 
syndrome type II, congenital deficiency in GnTII 
activity is associated with severe psychomotor 
retardation and other multisystemic abnormalities 
(45,46). In a mouse model with a homozygous null 
mutation in the gene encoding GnTII (Mgat2-/-), 
99% of newborns die during the first postnatal 
week (47). These developmental defects highlight 
the importance of complex N-glycans in 
intercellular communication and signalling in 
multicellular organisms. 
 The significance of complex N-glycans in 
the unicellular protozoan T. brucei is less well 
understood. In the bloodstream form, the parasite 
expresses both conventional biantennary complex 
N-glycans and unique highly extended and 
branched poly-N-acetyllactosamine-containing 
complex N-glycans (8,19,48,49). However, the T. 
brucei genome contains no obvious homologous 
of the canonical GnTI and GnTII genes that 
encode the β1-2GlcNAc transferases usually 
responsible for the initiation of complex N-
glycans. In a previous study, we identified and 
characterized TbGnTI, the enzyme responsible for 
the transfer β1-2GlcNAc to the Manα1-3 arm of 
N-glycan core structures (1). TbGnTI showed 
unusual activity in that it acts on biantennary 
Man3GlcNAc2 instead of triantennary 
Man5GlcNAc2, the preferred acceptor substrate 
for vertebrate GnTI activities (50). Remarkably, 
the TbGnTI gene is highly divergent from the 
canonical GnTI gene family and, despite the fact 
that TbGnTI catalyses a β1-2 linkage, it belongs to 
the so-called β3-glycosyltransferase superfamily 
(1,26). 
 In the current study, a reverse-genetics 
approach in T. brucei bloodstream form cells 
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indicated that the deletion of TbGT15 (another 
trypanosome β3-glycosyltransferase superfamily 
member) is accompanied by the absence of 
complex N-glycans, as well as alterations in the 
biosynthesis of the giant poly-LacNAc-containing 
glycans. Using a direct enzymatic assay and 
comprehensive product analysis, we could show 
that purified TbGT15 catalyzes the conversion of 
Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc 
to GlcNAcβ1-2Manα1-6(Manα1-3)Manβ1-
4GlcNAcβ1-4GlcNAc. We have therefore 
renamed TbGT15 to TbGnTII. The conversion of 
Man3GlcNAc2 demonstrates that TbGnTII works 
independently from prior TbGnTI action, which is 
in contrast to canonical GnTIIs that only use 
substrates after modification by GnTI, i.e. Manα1-
6(GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-
4GlcNAc (51,52). This unusual acceptor 
specificity of the trypanosome enzyme was 
already indicated by previous data which show the 
presence of “pseudohybrid” N-glycans in the 
absence of TbGnTI (1) and highlights the 
divergent nature of TbGnTII. A phylogram based 
on a multiple sequence alignment of TbGT15 and 
GnTII enzymes of other species is shown in Fig. 8. 
The GnTIIs of multicellular organisms belong the 
CAZy (carbohydrate-active enzymes) GT family 
13 (53) and are all closely related, with nearly 
90% identity between the human and mouse 
enzymes. In contrast, TbGnTII is a member of the 
CAZy GT 31 family (26) and shares only 9% 
identity with the human sequence at the amino 
acid level. Interestingly, while human GnTI and 
GnTII proteins have only a low level of amino 
acid sequence homology between them (22%), the 
TbGnTI and TbGnTII enzymes share 42% 
identity. This is consistent with the closer 
functional similarity of the trypanosome enzymes, 
which both work on the same acceptor substrate 
(Man3GlcNAc2, though only the latter requires the 
N-acetyl-chitobiose core), whereas the canonical 
GnTI and GnTII enzymes work on triantennary 
Man5GlcNAc2 and Manα1-6(GlcNAcβ1-2Manα1-
3)Manβ1-4GlcNAcβ1-4GlcNAc, respectively.  
Methylation linkage analysis of the poly-
LacNAc N-glycans of the TbGT15 null mutant 
showed a reduction in 6-O-substituted Gal and 3-
O-substituted Gal but an increase in 3,6-O-
substituted Gal. This allows us to augment our 
model of the parasites’ complex N-glycans and 
propose that the Manα1-6 arm is normally 
occupied by predominantly linear poly-LacNAc 
repeats and the Manα1-3 arm by branched as well 
as linear poly-LacNAc repeats (Fig. 7). 
T. brucei has an unusual dual N-
glycosylation mechanism with two paralogous 
oligosaccharyltransferases, TbSTT3A and 
TbSTT3B, that transfer biantennary 
Man5GlcNAc2 and triantennary Man9GlcNAc2, 
respectively, in a site-specific manner (15,16). 
Due to the absence of Golgi α-mannosidase II in 
the parasite, triantennary structures cannot be 
processed to complex N-glycans, rendering 
biantennary Man5GlcNAc2 transferred by STT3A 
the only route to paucimannose and complex 
structures. Further, the inability of TbGnTI to act 
on triantennary Man5GlcNAc2 (1) also means that 
biantennary Man5GlcNAc2 transferred by STT3A 
is the only possible route to pseudohybrid N-
glycans (i.e., those with only one arm of the 
trimannosyl-core modified by GlcNAc ± 
additional sugars). RNAi knockdown of TbSTT3A 
showed that cells are viable in culture, but not in 
mice (15). Interestingly, the deletion of TbGnTI 
(TbGT11) has no effect on in vitro growth rate and 
the infectivity to mice was indistinguishable from 
wild-type (1). This suggests that the presence of 
pseudohybrid N-glycans with glycan extensions to 
the 6-arm alone are sufficient to compensate the 
loss of complex N-glycans. Here, the in vitro and 
in vivo viability of the TbGnTII null mutant shows 
that the reverse is true, in that the presence of 
pseudohybrid structures with extensions to the 3-
arm alone compensates for the loss of complex N-
glycans. However, despite extensive attempts, a 
double knockout lacking both TbGnTI and 
TbGnTII genes could not be generated in our 
hands, suggesting that extension of one or other of 
the arms of the N-glycan trimannosyl-core is 
essential for the growth and infectivity of 
bloodstream form T. brucei. 
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FIGURE LEGENDS 
FIGURE 1. Generation of a bloodstream form TbGT15 null and conditional null mutant. A, Gene 
replacement strategy to create TbGT15 null mutant cells and subsequent insertion of tetracycline-
inducible ectopic copy, in brackets, to create a conditional null mutant. B, Southern blot of genomic DNA 
digested with EcoRI from WT (lanes 1, 3, 5) and TbGT15 null mutant cells (lanes 2, 4, 6). The blot was 
probed with a TbGT15 ORF probe (left-hand panel) and a TbGT15 3’UTR probe (middle panel) and 
shows the replacement of both alleles with drug resistance cassettes. Equal loading was verified by 
ethidium bromide staining (right-hand panel). C, Ethidium bromide-stained agarose gel of reverse 
transcription-PCR products from RNA extracted from WT cell, TbGT15 null and conditional null 
mutants: TbGT15 mRNA was detected in WT (lane 1) and TbGT15 conditional null mutant cells grown 
under permissive (plus tetracycline) conditions (lane 4), while no mRNA was found in TbGT15 null 
mutants (lane 2) and TbGT15 conditional null mutants grown under non-permissive conditions (lane 5). 
To show equal RNA input, a control using dolichol-phosphate mannose synthase (DPMS) primers was 
performed with TbGT15 null mutants (lane 3) and TbGT15 conditional null mutants grown under non-
permissive conditions (lane 6). 
 
FIGURE 2. The absence of TbGT15 does not affect bloodstream form trypanosome morphology 
and growth. A, Scanning electron micrographs of representative WT (left-hand panel) and TbGT15 null 
mutant cells (right-hand panel); scale bar = 2 µm. B, Growth curves for bloodstream form T. brucei wild-
type cells (WT; grey diamonds), TbGT15 null mutant cells (TbGT15DKO; black squares) and TbGT15 
conditional null mutant cells grown under permissive conditions (TbGT15cDKO; grey triangles). Cell 
counts were taken daily in triplicate, error bars indicate one standard deviation of the mean. C, infectivity 
of wild-type and TbGT15 null mutant bloodstream-from parasites to mice. Mice were infected with 5x105 
cells of WT (black) or TbGT15 null mutants (grey) and the number of parasites per ml blood was counted 
three days post-infection. No difference in infectivity was observed. 
 
FIGURE 3. sVSG221 glycoform analysis by ES-MS. Samples of intact sVSG of WT (A) and TbGT15 
null mutant trypanosomes (B) were analyzed by positive-ion ES-MS and the deconvolved spectra of the 
various isobaric glycoforms were generated (the compositions of these glycoforms are given in Table 1). 
Significant differences in the sVSG glycosylation patterns are indicated by arrows in panel B.  
 
FIGURE 4. TbGT15 in vitro functional activity assay. Fluorographs of HPTLC plates showing the 
products of: A, UDP-[3H]GlcNAc and anti-HA-conjugated magnetic bead immunoprecipitates from T. 
brucei expressing TbGT15-HA3 incubated with Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAc or 
Manα1-6(Manα1-3)Man (lane 1 or 3). As a negative control, anti-HA-conjugated magnetic beads 
incubated with lysates from cells not expressing TbGT15-HA3 were used with Manα1-3(Manα1-
6)Manβ1-4GlcNAcβ1-4GlcNAc (lane 2). B, The [3H]GlcNAcMan3GlcNAc2 reaction product before 
(lane 1) and after (lane 2) treatment with α1-2,3 mannosidase. C, The [3H]GlcNAcMan3GlcNAc2 
reaction product before (lane 1) and after (lane 2) treatment with β-N-acetylglucosaminidase. 
 
FIGURE 5. Mass spectrometry analysis of TbGT15 reaction product. HILIC-MS of in vitro assay 
reaction. A, Base peak chromatogram showing substrate HexNAc2Hex3 (13.36 min) and reaction product 
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HexNAc3Hex3 (13.57 min). B, Mass spectrum of HexNAc2Hex3 (substrate, S) and HexNAc3Hex3 
(product, P) in protonated and sodiated form ([S+H]+=911.51; [S+Na]+= 933.43;[P+H]+=1114.58; 
[P+Na]+=1136.55). C, GC-MS extracted ion chromatogram of ions (m/z 102, 118, 129, 117, 161, and 
190) characteristic for partially methylated alditol acetate (PMAA) derivatives obtained after 
permethylation, acid hydrolysis, sodium borodeuteride reduction, and peracetylation of the TbGT15 
reaction product. D, spectrum of the 1,2,5-tri-O-acetyl-(1-deutero)-3,4,6-tri-O-methyl-mannitol PMAA 
derived from 2-O-substituted mannose, with characteristic fragment ion assignments.    
 
FIGURE 6. Lectin blotting of VSG-depleted glycoproteins. Lysates of washed WT or TbGT15 null 
mutant (KO) trypanosome cell ghosts were subjected to SDS-PAGE and transferred to nitrocellulose 
membrane. The membrane was incubated with ricin (left-hand panel) or, as a binding specificity control, 
with ricin that was pre-incubating with 10 mg/ml each of galactose and lactose (middle panel). Equal 
loading and transfer is demonstrated by Ponceau S staining (right-hand panel). 
 
FIGURE 7. Proposed scheme for poly-LacNAc-containing N-glycans of bloodstream form 
trypanosomes. The data presented here and in (1) are consistent with the model shown here whereby in 
wild-type bloodstream form T. brucei the majority of large complex N-glycans carry highly branched 
poly-LacNAc chains on the Manα1-3 arm and predominantly linear poly-LacNAc chains on the Manα1-6 
arm. In the TbGT15 null mutant, all elaboration of the Manα1-6 arm is absent and partly compensated by 
an increase in the branched poly-LacNAc elaboration of the Manα1-3 arm. Note that the relative positions 
of branch points shown are arbitrary. 
 
FIGURE 8. Phylogenetic tree of GnTII amino acid sequences from different species. Amino acid 
sequences were aligned using the COBALT constraint-based multiple alignment program. GnTII: Oryza 
sativa (NP_001048400.2), Caenorhabditis elegans (NP_505864.1), Drosophila melanogaster 
(NP_651763.4), Anopheles gambiae (XP_313681.5) Danio rerio (NP_001077344.1), Xenopus tropicalis 
(NP_001006759.1), Homo sapiens (NP_002399.1), Mus musculus (NP_666147.1), Rattus norvegicus 
(NP_446056.1). The evolutionary distance is represented by the length of the horizontal lines. 
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TABLES 
MW [Da] 
WT/TbGT15 null mutant 
(Theo.) 
Proteina GlcN-Ino-cPb EtNP GlcNAc Man+Gal WT 
TbGT15 
null 
mutant 
50204/50202 (50194) 1 1 1 4 16 + c Traces 
50241/50242 (50235) 1 1 1 5 17 Traces + 
50366/50364 (50356) 1 1 1 4 17 + + 
50405/50404 (50397) 1 1 1 5 16 Traces + 
50528/50526 (50518) 1 1 1 4 18 +++ ++ 
50568/50566 (50559) 1 1 1 5 17 + Traces 
50608/NA (50600) 1 1 1 6 16 Traces - 
50690/50688 (50680) 1 1 1 4 19 +++ +++ 
50731/50728 (50721) 1 1 1 5 18 + + 
50770/NA (50762) 1 1 1 6 17 Traces - 
50852/50850 (50842)d 1 1 1 4 20 +++ +++ 
50893/50891 (50883) 1 1 1 5 19 ++ + 
50933/NA (50924) 1 1 1 6 18 + - 
51014/51012 (51004) 1 1 1 4 21 ++ +++ 
51055/51053 (51045) 1 1 1 5 20 +++ + 
51097/NA (51086) 1 1 1 6 19 + - 
51177/51175 (51166) 1 1 1 4 22 + + 
51217/51216 (51207) 1 1 1 5 21 ++ + 
51258/NA (51248) 1 1 1 6 20 + - 
51340/51337 (51328) 1 1 1 4 23 + + 
51380/51377 (51369) 1 1 1 5 22 + Traces 
51421/NA (51410) 1 1 1 6 21 + - 
51502/51500 (51490) 1 1 1 4 24 + + 
51542/51539 (51531) 1 1 1 5 23 + Traces 
51583/NA (51572) 1 1 1 6 22 + - 
51665/51662 (51652) 1 1 1 4 25 + Traces 
51706/51704 (51693) 1 1 1 5 24 + Traces 
51745/NA (51734) 1 1 1 6 23 Traces - 
 
TABLE 1. Isobaric glycoforms of sVSG221 identified by ES-MS. The molecular weights of different 
glycoforms of sVSG221 were calculated according to the indicated compositions (in brackets is the 
theoretical mass of the assigned VSG composition). The relative abundances of those glycoforms 
observed in Fig. 3 for sVSG preparations from sVSG of WT cells and TbGT15 null mutant cells are 
indicated by -, trace, +, ++, and +++ scores. 
a Protein Mr is based on the amino acid sequences of the VSG221 precursor (accession no. P26332) 
minus residues 1-27 (signal peptide) and 460-476 (GPI attachment signal peptide) and allows for four 
disulphide bonds (Mr=46284). 
b Components specific to the GPI anchor and common to all glycoforms: GlcN-Ino-cP, glucosamine-α1-
6-myo-inositol-1,2 cyclic phosphate; EtNP, ethanolamine phosphate. 
c Maximum entropy deconvolved spectra are only semi-quantitative; an indication of relative abundance 
of the isobaric glycoforms is given based on peak height. 
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d The most abundant glycoform of WT sVSG221 is expected to contain a GPI anchor of composition of 
Man3Gal5 (5), a C-terminal N-linked glycan of Man9GlcNAc2, and an internal N-linked glycan of 
Man3GlcNAc2 (8) (i.e. GlcNAc = 4, and Man = 20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 by guest on M
ay 26, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
T. brucei N-Acetylglucosaminyltransferase II 
18 
 
 
 
 
PMAA Derivative Origin WTa TbGT15 null 
mutanta 
2,4-Di-O-methyl-1,3,5,6-tetra-O-
acetyl-1-[2H]mannitol 
3,6-di-O-
substituted Man 
1.0 1.0 
3,4,6-Tri-O-methyl-1,2,5-tri-O-acetyl-
1-[2H]mannitol 
2-O-substituted 
Man 
2.3 2.3 
2,3,4,6-Tetra-O-methyl-1,5-di-O-
acetyl-1-[2H]galactitol 
Terminal Gal 
 
4.9 5.0 
2,4,6-Tri-O-methyl-1,3,5-tri-O-acetyl-
1-[2H]galactitol 
3-O-substituted Gal 
 
2.2 1.7 
(down 23%) 
2,3,4-Tri-O-methyl-1,5,6-tri-O-acetyl-
1-[2H]galactitol 
6-O-substituted Gal 
 
23.4 15.9  
(down 32%) 
2,4-Di-O-methyl-1,3,5,6-tetra-O-
acetyl-1-[2H]galactitol 
3,6-di-O-
substituted Gal 
3.6 5.0 
(up 39%) 
3,6-Di-O-methyl-1,4,5-tri-O-acetyl-2-
N-methylacetamido-1-
[2H]glucosaminitol 
4-O-substituted 
GlcNAc 
24.6b 16.6 b 
 
 
 
TABLE 2. Quantitative GC-MS methylation linkage analysis of the total poly-LacNAc fraction. The 
total poly-LacNAc fraction was permethylated, hydrolyzed, reduced and acetylated for GC-MS analysis. 
The resulting partially methylated alditol acetate (PMAA) derivatives were identified by retention time 
and electron impact mass spectra. Quantification was accomplished by integration of the total ion current 
using molar relative response factors deduced empirically from authentic standards, as described in 
Experimental Procedures.  
a Molar quantities relative to 3,6-di-O-substituted Man (one per glycan). 
b Values for N-acetylglucosamine derivatives are less reliable than for hexoses.  
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